Her primary areas of study are Neuroscience, Substantia nigra, Muscimol, Endocrinology and Internal medicine. Her Neuroscience research incorporates elements of Glutamate receptor, Pharmacology and GABAA receptor. Her study in Substantia nigra is interdisciplinary in nature, drawing from both Basal ganglia, Striatum, Forebrain and GABAergic.
Her Muscimol research is multidisciplinary, incorporating perspectives in Anticonvulsant, gamma-Aminobutyric acid, Basolateral amygdala and Developmental psychology. Endocrinology is closely attributed to Bicuculline in her study. Her Bicuculline research includes elements of Kynurenate, Convulsant, Midbrain tegmentum and Epilepsy.
Her primary areas of investigation include Neuroscience, Endocrinology, Internal medicine, Substantia nigra and Bicuculline. Her Neuroscience study combines topics in areas such as Kainic acid and Muscimol, GABAA receptor. Her study looks at the relationship between Endocrinology and fields such as Nerve growth factor, as well as how they intersect with chemical problems.
Her work on Stimulation as part of general Internal medicine research is frequently linked to Basic fibroblast growth factor, bridging the gap between disciplines. Her biological study spans a wide range of topics, including Superior colliculus, gamma-Aminobutyric acid, Striatum and GABAergic. The study incorporates disciplines such as Anticonvulsant, Epilepsy, Convulsant and Pharmacology in addition to Bicuculline.
Neuroscience, Phenobarbital, Epilepsy, Pharmacology and Muscimol are her primary areas of study. The concepts of her Neuroscience study are interwoven with issues in Bicuculline and GABAA receptor. Her Phenobarbital study is focused on Internal medicine in general.
Her research integrates issues of Brain damage and Endocrinology, Adult male in her study of Epilepsy. Her work deals with themes such as Anticonvulsant, Pentylenetetrazol, Neurotoxicity and Apoptosis, which intersect with Pharmacology. Her research in Muscimol intersects with topics in Analysis of variance, Basolateral amygdala, Developmental psychology, Extinction and Basal ganglia.
Karen Gale mostly deals with Phenobarbital, Neuroscience, Pharmacology, Neurotoxicity and Piriform cortex. Karen Gale has included themes like Anesthesia, Prepulse inhibition, Phenytoin and Physiology in her Phenobarbital study. The various areas that Karen Gale examines in her Neuroscience study include Developmental psychology and GABAA receptor, Muscimol.
Karen Gale works in the field of GABAA receptor, focusing on Bicuculline in particular. Her work on Drug as part of general Pharmacology research is often related to Sodium channel blocker, thus linking different fields of science. Her Piriform cortex research is multidisciplinary, relying on both Seizure activity, Epileptogenesis, Temporal lobe, Epilepsy and Entorhinal cortex.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Substantia nigra: site of anticonvulsant activity mediated by gamma-aminobutyric acid.
Michael J. Iadarola;Karen Gale.
A crucial epileptogenic site in the deep prepiriform cortex
Salvatore Piredda;Karen Gale.
Spinal cord contusion in the rat: Behavioral analysis of functional neurologic impairment
Karen Gale;Harry Kerasidis;Jean R. Wrathall.
Experimental Neurology (1985)
Subcortical structures and pathways involved in convulsive seizure generation.
Journal of Clinical Neurophysiology (1992)
Dopamine-sensitive adenylate cyclase: location in substantia nigra.
K. Gale;Alessandro Guidotti;E. Costa.
Progression and generalization of seizure discharge: anatomical and neurochemical substrates.
Seizure protection and increased nerve-terminal GABA: delayed effects of GABA transaminase inhibition
Karen Gale;Michael J. Iadarola.
Presence of substance P and GABA in separate striatonigral neurons.
Karen Gale;Jau Shyong Hong;Alessandro Guidotti.
Brain Research (1977)
Dynamic utilization of GABA in substantia nigra: regulation by dopamine and GABA in the striatum, and its clinical and behavioral implications
K. Gale;M. Casu.
Molecular and Cellular Biochemistry (1981)
Substantia nigra-mediated anticonvulsant actions: Role of nigral output pathways
Douglas S. Garant;Karen Gale.
Experimental Neurology (1987)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: